Imaging for Body Composition Trials: Opportunities and Considerations
Webinar
Imaging for Body Composition Trials: Opportunities and Considerations
The development of new treatments for body composition disorders is evolving and so is the advancement of imaging biomarkers. Though quantification of muscle and fat is not new, the options available to delineate and quantify muscle and lean mass are getting more sophisticated these days, leaving many sponsors with questions about how to best define their clinical trial endpoints.
Determining which imaging modality, anatomical coverage, and analysis methods to use can be critical to your trial outcomes. As the field explores new ways of deriving endpoints and exploring trends to support decisions, it is also prudent to appreciate what are the standard and validated endpoints that can be obtained based on the imaging modality.
Join us while our body composition imaging experts review the imaging modalities and analysis methods currently available to quantify body composition, including the benefits and limitations of the various options in the context of multi-center clinical trials.
Presenters:
Sally Warner, PhD, VP, Scientific and Medical Services, Perceptive
Farhan Syed, PhD, Medical Director, Perceptive
